Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Int J Health Policy Manag ; 4(2): 85-90, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25674571

RESUMO

BACKGROUND: Employee engagement is the emotional commitment of the employee towards the organisation. We aimed to analyse baseline work engagement using Utrecht Work Engagement Scale (UWES) at a teaching hospital. METHODS: We have conducted a cross-sectional study within the National Health Service (NHS) Teaching Hospital in the UK. All participants were working age population from both genders directly employed by the hospital. UWES has three constituting dimensions of work engagement as vigor, dedication, and absorption. We conducted the study using UWES-9 tool. Outcome measures were mean score for each dimension of work engagement (vigor, dedication, absorption) and total score compared with control score from test manual. RESULTS: We found that the score for vigor and dedication is significantly lower than comparison group (P< 0.0001 for both). The score for absorption was significantly higher than comparison group (P< 0.0001). However, total score is not significantly different. CONCLUSION: The study shows that work engagement level is below average within the NHS employees. Vigor and dedication are significantly lower, these are characterised by energy, mental resilience, the willingness to invest one's effort, and persistence as well as a sense of significance, enthusiasm, inspiration, pride, and challenge. The NHS employees are immersed in work. Urgent need to explore strategies to improve work engagement as it is vital for improving productivity, safety and patient experience.

3.
Br J Haematol ; 156(5): 588-600, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22512001

RESUMO

Iron deficiency is the most common deficiency state in the world, affecting more than 2 billion people globally. Although it is particularly prevalent in less-developed countries, it remains a significant problem in the developed world, even where other forms of malnutrition have already been almost eliminated. Effective management is needed to prevent adverse maternal and pregnancy outcomes, including the need for red cell transfusion. The objective of this guideline is to provide healthcare professionals with clear and simple recommendations for the diagnosis, treatment and prevention of iron deficiency in pregnancy and the postpartum period. This is the first such guideline in the UK and may be applicable to other developed countries. Public health measures, such as helminth control and iron fortification of foods, which can be important to developing countries, are not considered here. The guidance may not be appropriate to all patients and individual patient circumstances may dictate an alternative approach.


Assuntos
Anemia Ferropriva/diagnóstico , Anemia Ferropriva/terapia , Deficiências de Ferro , Complicações Hematológicas na Gravidez/diagnóstico , Complicações Hematológicas na Gravidez/terapia , Anemia Ferropriva/epidemiologia , Anemia Ferropriva/prevenção & controle , Suplementos Nutricionais , Feminino , Humanos , Ferro/uso terapêutico , Período Pós-Parto , Gravidez , Complicações Hematológicas na Gravidez/epidemiologia , Complicações Hematológicas na Gravidez/prevenção & controle , Resultado da Gravidez , Prevalência , Reino Unido
4.
BJOG ; 112(8): 1054-60, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16045517

RESUMO

OBJECTIVE: To explore the views of health professionals on the factors influencing repeat caesarean section. DESIGN: Qualitative study involving semi-structured interviews with professionals who care for women in pregnancy and labour. SETTING: Acute hospital trust with two maternity units and community midwifery service, Leicestershire, UK. SAMPLE: Twenty-five midwives and doctors. METHODS: Interviews with professionals were undertaken using a prompt guide. All interviews were audiotaped and transcribed verbatim. Analysis was based on the constant comparative method, assisted by QSR N5 software. MAIN OUTCOME MEASURES: Identification of factors influencing professional decision making about repeat caesarean section. RESULTS: Decision making in relation to repeat caesarean is a complex process involving several parties. Professionals identify the relevance of evidence for decision making for repeat caesarean. However, professionals feel that following strict protocols is of limited value because of the perceived substandard quality of evidence in this area, other external pressures and the contingent, unique and often unanticipated features of each case. Professionals also perceive that the organisation of care plays an important role in rates of repeat caesarean. CONCLUSIONS: Decision making for repeat caesarean is a social practice where standardised protocols may have limited value. Attention needs to be given to the multiple parties involved in the decision-making process. Reflective practice, opinion leadership and role modelling may offer ways forward but will require evaluation.


Assuntos
Atitude do Pessoal de Saúde , Atitude Frente a Saúde , Recesariana/estatística & dados numéricos , Tocologia/métodos , Obstetrícia/métodos , Prática Profissional/organização & administração , Recesariana/psicologia , Tomada de Decisões , Inglaterra , Feminino , Humanos , Masculino , Gravidez , Cuidado Pré-Natal/organização & administração , Relações Profissional-Paciente
5.
Thromb Res ; 115(6): 461-7, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15792676

RESUMO

INTRODUCTION: There is much interest in the relationship between coagulation status and complications of pregnancy. The thrombelastograph (TEG) has been proposed as a useful, inexpensive tool to screen for patients with hypercoagulable states. MATERIALS AND METHODS: We investigated 588 unselected pregnant women at booking, obtaining blood samples for TEG and thrombophilia investigation. Pregnancy outcome data was recorded. RESULTS: We found significant correlations between TEG parameters and the Prothrombin time (PT) and Activated Partial Thromboplastin time (APTT) (p<0.01) and with plasma Antithrombin level (p<0.01). There was no correlation between TEG and other thrombophilic defects (protein C, protein S, Factor V Leiden mutation, Prothrombin G20210A mutation, MTHFR C677T mutation and Lupus Anticoagulant). There was a significant association of TEG parameters with mid-trimester loss (MTL) but not with other adverse pregnancy outcomes. CONCLUSIONS: The correlation between TEG and PT, APTT and antithrombin level supports its value in providing a global measure of haemostasis. Coagulation status at booking is associated with increased risk of MTL but not with complications occurring later in pregnancy.


Assuntos
Complicações na Gravidez/epidemiologia , Trombofilia/diagnóstico , Trombofilia/epidemiologia , Adolescente , Adulto , Testes de Coagulação Sanguínea/instrumentação , Testes de Coagulação Sanguínea/métodos , Comorbidade , Feminino , Humanos , Valor Preditivo dos Testes , Gravidez , Complicações na Gravidez/sangue , Terceiro Trimestre da Gravidez , Estudos Prospectivos , Fatores de Risco , Tromboelastografia/instrumentação , Tromboelastografia/normas , Trombofilia/genética , Fatores de Tempo , Reino Unido/epidemiologia , Tempo de Coagulação do Sangue Total
6.
Br J Haematol ; 127(2): 204-8, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15461627

RESUMO

Thromboembolic disease remains the leading cause of maternal death in the UK. Recent literature has proposed that folate status is a strong predictor for venous thrombosis. Using thrombelastography (TEG((R))), we tested the hypothesis that folic acid supplementation is associated with a reduction in whole blood coagulability. Blood samples and questionnaire data were obtained at a mean gestation of 13.6 weeks (SD: 3.8, range: 6-38 weeks) from unselected consecutive women attending for their antenatal booking scan. Of 588 patients, 439 (74.7%) took folic acid. All TEG((R)) parameters were less hypercoagulable in women that had taken folic acid compared with those that had not: mean maximum amplitude (MA) 60.3 versus 62.1; mean difference 1.8; 95% confidence interval 0.8, 2.8; P = 0.0001; mean coagulation index (CI) 0.54 versus 0.85; mean difference 0.31; 95% confidence interval 0.11, 0.5; P = 0.002. There was no difference in the incidence of the homozygous MTHFR mutation in patients taking folic acid (5.53%) compared with those that were not (4.08%). This study suggests that benefit may be derived from longer-term treatment, although large multicentre studies are required to determine whether the relative hypocoagulability is associated with a reduction in risk of venous thrombosis.


Assuntos
Suplementos Nutricionais , Ácido Fólico/administração & dosagem , Complicações Cardiovasculares na Gravidez/prevenção & controle , Trombose Venosa/prevenção & controle , Adulto , Coagulação Sanguínea , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Feminino , Humanos , Estado Nutricional , Gravidez , Tromboelastografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA